• Home
• Mailbox
• Boards
• Favorites
• Whats Hot!
• Login - Join Now!

Search Search Type Board Post Member

Profile

About Latest Posts Latest Blog Posts Boards Posted On Boards Moderating

tlc2's Profile

Avatar:

Membership:

Premium

Person Marks:

3

Total Posts:

2

Total Blog Posts:

0

Total Compensated Posts:

0

Moderating:

0

Alias Born

03/10/2012 7:20:17 AM

Personal info

Recent Articles

• GlobalFoundries Unveils Powerful 130CBIC SiGe Platform
• Alarum Technologies Reports Impressive Q2 2025 Financial Results
• Surge in Silver Prices Sparks Interest in Sprott ETFs
• Jim Cramer Highlights Rigetti's Speculative Growth Potential
• Cooper Companies Faces Setback in Pre-Market Trading Today
• Perimeter Medical Welcomes Dr. Ted James as New CMO
• NurExone Biologic Inc. Reports Financial Progress and Updates
• Alarum Technologies Reports Positive Q2 2025 Financial Results
• Analysts Update Expectations for Marvell Technology Earnings
• Startek® Achieves Prestigious Women Empowerment Certification
• 2025 Automotive Brand Loyalty Trends Highlight Changes Ahead
• CGI Enhances Its Digital Services with Apside Acquisition
• Dominari Holdings Unveils Strategic $2 Billion Fund for Growth
• CTO Realty Growth, Inc. Faces Class Action Lawsuit Concerns
• The St. James Reinvents Lacrosse with Spencer Ford at the Helm
• GraniteShares Unveils Weekly Distribution for YieldBOOST ETFs
• SOLOWIN Innovates Tokenized Asset Transparency with Chainlink
• ARS Pharmaceuticals Schedules Key Presentations for Investors
• Kyverna Therapeutics Advances Innovative CAR T Therapy for MG
• Seluna Advances Pediatric Sleep Diagnostics with New Study
• CytomX Therapeutics Engages Investors at Key Conferences
• Exploring the Growth of Parkinson's Disease Therapies to 2034
• Psyence BioMed, a Leader in Psychedelic Medicine, Pursues Growth
• Kot Auto Group Partners with AutoTrader.ca to Boost Sales
• CryptoVirally Enhances Web3 Marketing Services for Growth
• Marker Therapeutics' Strategic Participation in Key Conference
• NurExone Biologic Inc. Reports Strong Q2 Financial Outcomes
• ExlService Holdings Plans to Engage at Citi TMT Conference
• Catalyst Pharmaceuticals Gears Up for Key Investor Engagements
• CF Energy Reports Comprehensive Financial Performance Analysis
• Celebrate Racing Excellence at Kentucky Downs' Rich Events
• Marker Therapeutics CEO to Speak at Key Investment Conference
• Candel Therapeutics Announces Participation in Key Investor Events
• EXL's Key Presentation at the Citi Global TMT Conference
• Join VEON and Kyivstar for Key Insights into Future Growth
• Catalyst Pharmaceuticals Engages Investors at Key Conferences
• Czech Army Strengthens Defense with BAE Systems' New Vehicle
• Ribbon Communications Enhances Defense Solutions for Secure Networks
• Understanding XRP's Market Dynamics and Ongoing Criticism
• Candel Therapeutics to Engage Investors at Major Conferences
• LakeShore Biopharma Engages in Acquisition Talks Amid Growth
• Maximizing Your Income: How Dell Stock Can Yield Dividends
• Understanding Apax Global Alpha Ltd’s Recent Position Disclosure
• BestEx Research Welcomes Charlie Whitlock as Managing Director
• Investors Eye Strong Dividends from Top Consumer Stocks
• Rathbones Group's Stake in Empiric Student Property Explained
• MUSINSA's Impressive Q2 2025 Financial Performance Unveiled
• Key Disclosure Insights for Life Science REIT Investors
• Thomson Reuters and More: Analysts Upgrade Key Stocks Today
• AirNet Technology Inc. Secures $180 Million in Notable Offering